These observations complement elegant recent animal model work showing that treatment with BTKi decreases B-cell costimulatory molecule expression and limits B-cell APC function in experimental autoimmune encephalomyelitis, the commonly used animal model of MS [52]. Here, IBTK is linked to experimental autoimmune encephalomyelitis.